Table 4 observed side-effects classified according to Common Terminology Criteria Adverse Events, version 4.0, during short-term follow-up (6 months after SBRT)
CTCAE, version 4.0 | |||||
|---|---|---|---|---|---|
Component and disorders | 0 | 1 | 2 | 3 | 4 |
General disorder, fatigue | 43 (100) | 0 (0) | 0 (0) | 0 (0) | |
Cough | 37(88.4) | 4(9.3) | 1(2.3) | 0 (0) | |
Dyspnea | 42 (97.7) | 1 (2.3) | 0 (0) | 0 (0) | 0 (0) |
Pneumonitis | 25 (58.1) | 15 (34.9) | 3(7.0) | 0(0) | |
Esophagitis | 42 (97.7) | 1 (2.3) | 0 (0) | 0 (0) | 0 (0) |
Rib fractures | 43 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Chest wall pain | 43 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Pleural and pericardial effusion | 43 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |